Evidence map›Paper›PMID 33824633›Full record

ReviewEnvironmental chemistry letters2021

Smarter cures to combat COVID-19 and future pathogens: a review.

Han Dai, Jie Han, Eric Lichtfouse

Abstract readReview
In one paragraph

Review in Environmental chemistry letters, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. COVID-19: Reducing the risk via diet and lifestyle.Journal of integrative medicine · 2023
    Review
  3. Review
  4. Article
  5. Review
  6. Observational
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. River therapy.Environmental chemistry letters · 2022
    Article
  14. Review
  15. Article
  16. Review
  17. Nanozymes to fight the COVID-19 and future pandemics.Environmental chemistry letters · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Han DaiDepartment of Environmental Science and Engineering, Xi'an Jiaotong University, Xi'an, 710049 People's Republic of China.
Jie HanDepartment of Environmental Science and Engineering, Xi'an Jiaotong University, Xi'an, 710049 People's Republic of China.ORCID 0000-0001-6790-0650
Eric LichtfouseCNRS, IRD, INRAE, Coll France, CEREGE, Aix-Marseille University, 13100 Aix en Provence, France.ORCID 0000-0002-8535-8073

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prevention is better than cure. A milestone of the anthropocene is the emergence of a series of epidemics and pandemics often characterized by the transmission of a pathogen from animals to human in the past two decades. In particular, the coronavirus disease 2019 (COVID-19) has made a profound impact on emergency responding and policy-making in a public health crisis. Classical solutions for controlling the virus, such as travel restrictions, lockdowns, repurposed drugs and vaccines, are socially unpopular and medically limited by the fast mutation and adaptation of the virus. This is exacerbated by microbial resistance to therapeutic drugs and the slowness of vaccine development. In other words, microbial pathogens are somehow 'smarter' and faster than us, thus calling for more intelligent cures to combat future pandemics. Here, we compare therapeutics for COVID-19 such as synthetic drugs, vaccines, antibodies and phages. We present the strength and limitations of antibiotic and antiviral drugs, vaccines, and antibody-based therapeutics. We describe smarter, cheaper and preventive cures such as bacteriophages, food medicine using probiotics and prebiotics, sports, healthy diet, music, yoga, Tai Chi, dance, reading, knitting, cooking and outdoor activities. Some of these preventive cures have been intuitively developed since thousands of years ago, as illustrated by the fascinating similarity of the Chinese characters for 'music' and 'herbal medicine.'

Indexed as

CoronavirusImmune systemImmunotherapyMicrobial resistanceProbioticsSARS-CoV-2

Identifiers

PMID33824633
PMCPMC8017513

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.